Effects of ranitidine and nizatidine on the risk of gastrointestinal cancer

• Published in: Frontiers in Oncology Vol. 13; p. 1182174
• Main Authors: Kang, Hyejung, Nam, Chung Mo, Choi, Dong-Woo, Park, Sohee
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media SA 27.07.2023; Frontiers Media S.A
• Subjects: gastrointestinal cancer; H2-receptor antagonists; National Health Insurance Service-National Sample Cohort; nationwide health claims data; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; nizatidine; Oncology; ranitidine; RC254-282; retrospective cohort study; ranitidine; gastrointestinal cancer; nizatidine; National Health Insurance Service-National Sample Cohort; nested case-control study; H2-receptor antagonists; nationwide health claims data

Gastrointestinal (GI) cancer occurs in digestive organs such as the stomach, colon, liver, esophagus, and pancreas. About 83,034 cases occurred in Korea alone in 2020. Dietary factors, alcohol consumption, ( ), and lifestyle factors increase the incidence of diseases such as gastritis, peptic ulcer,...